Phase I Study of SHR-2173 Injection in Patients With Primary Immune Thrombocytopenia

Efficacy and Safety Study of Maintenance Treatment With rhTPO in Thrombocytopenic Subjects With ITP

NCT01805648 ·Status: UNKNOWN ·Phase: PHASE3

A Study of Zanubrutinib in Patients With ITP

NCT05279872 ·Status: COMPLETED ·Phase: PHASE2

A Phase Ib/II Clinical Trial of Multiple Doses of STSA-1301 Subcutaneous Injection in Healthy Subjects and Patients With Immune Thrombocytopenia (ITP)

NCT06929299 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Clinical Trial to Assess Safety and Efficacy of Daratumumab in the Treatment of Primary Immune Thrombocytopenia

NCT05562882 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)

NCT07297563 ·Status: RECRUITING ·Phase: PHASE2

Anti-CD38 Antibody Treating Elderly Patients With Primary Immune Thrombocytopenia (ITP)

NCT07063199 ·Status: RECRUITING ·Phase: PHASE2

National Multicenter Retrospective Real-World Study on the Treatment Status of Newly Diagnosed and Persistent Primary Immune Thrombocytopenia (ITP) Patients

NCT07268898 ·Status: NOT_YET_RECRUITING

Safety and Efficacy of PRG-1801 in Recurrent/Refractory Primary Immune Thrombocytopenia (ITP)

NCT06519565 ·Status: RECRUITING ·Phase: EARLY_PHASE1

The Safety and Tolerability of STSA-1301 Subcutaneous Injection in Healthy Subjects

NCT06148389 ·Status: COMPLETED ·Phase: PHASE1

An Investigation of rhTPO With Different Frequencies in the Management of ITP

NCT02139501 ·Status: COMPLETED ·Phase: PHASE3

A Prospective, One-arm and Open Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia

NCT05694767 ·Status: COMPLETED ·Phase: PHASE2

A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia

NCT06721013 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Efficacy and Safety of Romiplostim N01 Combined With Rituximab in Patients With Oral TPO-RA-Refractory Primary Immune Thrombocytopenia

NCT07206823 ·Status: RECRUITING ·Phase: NA

A First in HumanTrial to Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-06755347

NCT03275740 ·Status: TERMINATED ·Phase: PHASE1

Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia

NCT05070845 ·Status: RECRUITING ·Phase: PHASE2

Lusutrombopag in the Treatment of Immune Thrombocytopenia (ITP)

NCT06287567 ·Status: COMPLETED ·Phase: PHASE2

rhTPO Combining Rituximab Versus Low-dose Rituximab in Management of ITP

NCT01525836 ·Status: COMPLETED ·Phase: PHASE3

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

NCT06948318 ·Status: RECRUITING ·Phase: PHASE3

The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP)

NCT06291415 ·Status: WITHDRAWN ·Phase: PHASE1

A Study on the Safety and Efficacy of TQB3473 Tablets in the Treatment of Persistent or Chronic Primary Immune Thrombocytopenia (ITP) in Adults

NCT07083739 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Recombinant Human Thrombopoietin in Combination With Rituximab in Immune Thrombocytopenia (ITP)

NCT01506414 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Study on the Efficacy and Safety of Herombopag in the Treatment of Senile Primary ITP

NCT06838949 ·Status: RECRUITING ·Phase: PHASE2

Extension Study of Herombopag for Pediatric Patients With Chronic Immune Thrombocytopenia

NCT05685420 ·Status: UNKNOWN ·Phase: PHASE3

Optimal Dose of Zanubrutinib to Treat Adult Immune Thrombocytopenia

NCT07315373 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

The Study of Different Dose Rituximab in the Treatment of ITP

NCT03258866 ·Status: COMPLETED ·Phase: PHASE4